• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找小分子校正剂的组合以恢复F508del-囊性纤维化跨膜传导调节因子的功能和加工过程。

Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.

作者信息

Boinot Clément, Jollivet Souchet Mathilde, Ferru-Clément Romain, Becq Frédéric

机构信息

Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, Centre National de la Recherche Scientifique (CNRS), Poitiers, France.

Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, Centre National de la Recherche Scientifique (CNRS), Poitiers, France

出版信息

J Pharmacol Exp Ther. 2014 Sep;350(3):624-34. doi: 10.1124/jpet.114.214890. Epub 2014 Jun 26.

DOI:10.1124/jpet.114.214890
PMID:24970923
Abstract

The mutated protein F508del-cystic fibrosis transmembrane conductance regulator (CFTR) failed to traffic properly as a result of its retention in the endoplasmic reticulum and functions as a chloride (Cl(-)) channel with abnormal gating and endocytosis. Small chemicals (called correctors) individually restore F508del-CFTR trafficking and Cl(-) transport function, but recent findings indicate that synergistic pharmacology should be considered to address CFTR defects more clearly. We studied the function and maturation of F508del-CFTR expressed in HeLa cells using a combination of five correctors [miglustat, IsoLAB (1,4-dideoxy-2-hydroxymethyl-1,4-imino-l-threitol), Corr4a (N-[2-(5-chloro-2-methoxy-phenylamino)-4'-methyl-[4,5']bithiazolyl-2'-yl]-benzamide), VX-809 [3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid], and suberoylamilide hydroxamic acid (SAHA)]. Using the whole-cell patch-clamp technique, the current density recorded in response to CFTR activators (forskolin + genistein) was significantly increased in the presence of the following combinations: VX-809 + IsoLAB; VX-809 + miglustat + SAHA; VX-809 + miglustat + IsoLAB; VX-809 + IsoLAB + SAHA; VX-809 + miglustat + IsoLAB + SAHA. These combinations restored the activity of F508del-CFTR but with a differential effect on the appearance of mature c-band of F508del-CFTR proteins. Focusing on the VX-809 + IsoLAB cocktail, we recorded a level of correction higher at 37°C versus room temperature, but without amelioration of the thermal instability of CFTR. The level of functional rescue with VX-809 + IsoLAB after 4 hours of incubation was maximal and similar to that obtained in optimal conditions of use for each compound (i.e., 24 hours for VX-809 + 4 hours for IsoLAB). Finally, we compared the stimulation of F508del-CFTR by forskolin or forskolin + VX-770 [N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide] with cells corrected by VX-809 + IsoLAB. Our results open new perspectives for the development of a synergistic polypharmacology to rescue F508del-CFTR and show the importance of temperature on the effect of correctors and on the level of correction, suggesting that optimized combination of correctors could lead to a better rescue of F508del-CFTR function.

摘要

突变蛋白F508del-囊性纤维化跨膜传导调节因子(CFTR)由于滞留在内质网而无法正常转运,并作为具有异常门控和内吞作用的氯离子(Cl(-))通道发挥作用。小分子化合物(称为校正剂)可单独恢复F508del-CFTR的转运和Cl(-)转运功能,但最近的研究结果表明,应考虑采用协同药理学来更明确地解决CFTR缺陷问题。我们使用五种校正剂[米格鲁司他、IsoLAB(1,4-二脱氧-2-羟甲基-1,4-亚氨基-l-苏糖醇)、Corr4a(N-[2-(5-氯-2-甲氧基-苯氨基)-4'-甲基-[4,5']联噻唑-2'-基]-苯甲酰胺)、VX-809 [3-(6-(1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙烷甲酰胺基)-3-甲基吡啶-2-基)苯甲酸]和辛二酰苯胺异羟肟酸(SAHA)]的组合,研究了在HeLa细胞中表达的F508del-CFTR的功能和成熟情况。使用全细胞膜片钳技术,在以下组合存在时,对CFTR激活剂(福斯可林 + 染料木黄酮)响应记录的电流密度显著增加:VX-809 + IsoLAB;VX-809 + 米格鲁司他 + SAHA;VX-809 + 米格鲁司他 + IsoLAB;VX-809 + IsoLAB + SAHA;VX-809 + 米格鲁司他 + IsoLAB + SAHA。这些组合恢复了F508del-CFTR的活性,但对F508del-CFTR蛋白成熟c带的出现有不同影响。聚焦于VX-809 + IsoLAB混合物,我们记录到37°C时的校正水平高于室温,但CFTR的热不稳定性没有改善。孵育4小时后,VX-809 + IsoLAB的功能挽救水平最高,与每种化合物在最佳使用条件下获得的水平相似(即VX-809为24小时 + IsoLAB为4小时)。最后,我们比较了福斯可林或福斯可林 + VX-770 [N-(2,4-二叔丁基-5-羟基苯基)-4-氧代-1,4-二氢喹啉-3-甲酰胺]对F508del-CFTR的刺激与经VX-809 + IsoLAB校正的细胞。我们的结果为开发协同多药理学以挽救F508del-CFTR开辟了新的前景,并表明温度对校正剂效果和校正水平的重要性,表明校正剂的优化组合可能导致更好地挽救F508del-CFTR功能。

相似文献

1
Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.寻找小分子校正剂的组合以恢复F508del-囊性纤维化跨膜传导调节因子的功能和加工过程。
J Pharmacol Exp Ther. 2014 Sep;350(3):624-34. doi: 10.1124/jpet.114.214890. Epub 2014 Jun 26.
2
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.解析突变 F508del-CFTR 更易受四种囊性纤维化校正剂作用的区域。
Int J Mol Sci. 2019 Nov 1;20(21):5463. doi: 10.3390/ijms20215463.
3
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis.NBD2 对于基于噻唑的分子对 F508del CFTR 突变体的挽救是必需的:囊性纤维化多药物治疗的 II 类矫正剂。
Biomolecules. 2021 Sep 28;11(10):1417. doi: 10.3390/biom11101417.
4
Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.人源和鼠源 F508del-CFTR 的热稳定性差异及其对囊性纤维化跨膜电导调节因子增效剂的反应。
Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1;317(1):L71-L86. doi: 10.1152/ajplung.00034.2019. Epub 2019 Apr 10.
5
Identification of novel F508del-CFTR traffic correctors among triazole derivatives.鉴定三氮唑衍生物中新型 F508del-CFTR 转运校正剂。
Eur J Pharmacol. 2023 Jan 5;938:175396. doi: 10.1016/j.ejphar.2022.175396. Epub 2022 Nov 19.
6
Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR.RDR01752 作用机制的表征:一种新型 F508del-CFTR 校正剂。
Biochem Pharmacol. 2020 Oct;180:114133. doi: 10.1016/j.bcp.2020.114133. Epub 2020 Jul 3.
7
Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction.回复突变体、低温和校正剂揭示了VX-809挽救F508del-CFTR的机制,并提示多种药物可实现完全校正。
Chem Biol. 2013 Jul 25;20(7):943-55. doi: 10.1016/j.chembiol.2013.06.004.
8
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment.双校正剂治疗部分挽救 F508del-CFTR 的稳定性和运输缺陷。
Int J Mol Sci. 2021 May 17;22(10):5262. doi: 10.3390/ijms22105262.
9
Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222.ABBV-2222/GLPG2222 对 F508delCFTR 蛋白处理的生物学特征分析。
J Pharmacol Exp Ther. 2020 Jan;372(1):107-118. doi: 10.1124/jpet.119.261800. Epub 2019 Nov 15.
10
KCa3.1 potentiation stimulates Cl secretion in F508del and G551D CFTR-corrected primary human bronchial epithelial cells.KCa3.1 增强剂刺激 F508del 和 G551D CFTR 校正的原发性人支气管上皮细胞中的 Cl 分泌。
Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1215-C1230. doi: 10.1152/ajpcell.00319.2022. Epub 2022 Sep 5.

引用本文的文献

1
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis.NBD2 对于基于噻唑的分子对 F508del CFTR 突变体的挽救是必需的:囊性纤维化多药物治疗的 II 类矫正剂。
Biomolecules. 2021 Sep 28;11(10):1417. doi: 10.3390/biom11101417.
2
Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells.反映促炎状态的人附睾蛋白4(HE4)的表达增强受囊性纤维化支气管上皮细胞中CFTR的调控。
Front Pharmacol. 2021 May 14;12:592184. doi: 10.3389/fphar.2021.592184. eCollection 2021.
3
Vardenafil increases intracellular accumulation of the most prevalent mutant cystic fibrosis transmembrane conductance regulator (CTFR) in human bronchial epithelial cells.
伐地那非增加人支气管上皮细胞中最常见的突变囊性纤维化跨膜电导调节因子(CTFR)的细胞内积累。
Biol Open. 2020 Aug 25;9(8):bio053116. doi: 10.1242/bio.053116.
4
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.合成与应用在囊性纤维化治疗中的亚氨基糖
Int J Mol Sci. 2020 May 9;21(9):3353. doi: 10.3390/ijms21093353.
5
Short-term consequences of F508del-CFTR thermal instability on CFTR-dependent transepithelial currents in human airway epithelial cells.F508del-CFTR 热不稳定性对人呼吸道上皮细胞 CFTR 依赖的跨上皮电流的短期影响。
Sci Rep. 2019 Sep 24;9(1):13729. doi: 10.1038/s41598-019-50066-7.
6
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction.一种新型三联药物伴侣分子可改善 F508del-CFTR 的校正。
Sci Rep. 2018 Jul 30;8(1):11404. doi: 10.1038/s41598-018-29276-y.
7
Detection of CFTR function and modulation in primary human nasal cell spheroids.检测原代人鼻腔细胞球体中的 CFTR 功能和调节。
J Cyst Fibros. 2018 Jan;17(1):26-33. doi: 10.1016/j.jcf.2017.06.010. Epub 2017 Jul 13.
8
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.增加囊性纤维化跨膜传导调节因子F508del等位基因的内质网储备可导致小分子疗法对其进行更大程度的折叠校正。
PLoS One. 2016 Oct 12;11(10):e0163615. doi: 10.1371/journal.pone.0163615. eCollection 2016.
9
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines.新型羟基吡唑啉对ΔF508-和G551D-CFTR介导的氯离子电流的增强作用
PLoS One. 2016 Feb 10;11(2):e0149131. doi: 10.1371/journal.pone.0149131. eCollection 2016.
10
Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease.利用小分子校正剂挽救ATP结合盒蛋白ABCA4的贩运突变体作为治疗斯塔加特眼病的方法
J Biol Chem. 2015 Aug 7;290(32):19743-55. doi: 10.1074/jbc.M115.647685. Epub 2015 Jun 19.